Word

VIMULUS

Status

Dead

Status Code

606

Status Date

Monday, November 24, 2014

Serial Number

85450216

Mark Type

4000

Filing Date

Tuesday, October 18, 2011

Published for Opposition

Tuesday, February 28, 2012

Abandoned Date

Monday, November 24, 2014

Trademark Owner History

Glaxo Group Limited - Owner At Publication

Classifications

5 (Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Events

Nov 24, 2014

Abandonment Notice Mailed - No Use Statement Filed

Nov 24, 2014

Abandonment - No Use Statement Filed

Mar 6, 2014

Notice Of Approval Of Extension Request E-Mailed

Mar 5, 2014

Extension 4 Granted

Feb 25, 2014

Extension 4 Filed

Feb 25, 2014

Teas Extension Received

Oct 22, 2013

Notice Of Approval Of Extension Request E-Mailed

Oct 21, 2013

Extension 3 Granted

Oct 14, 2013

Extension 3 Filed

Oct 14, 2013

Teas Extension Received

Apr 27, 2013

Notice Of Approval Of Extension Request E-Mailed

Apr 26, 2013

Extension 2 Granted

Apr 5, 2013

Extension 2 Filed

Apr 26, 2013

Case Assigned To Intent To Use Paralegal

Apr 5, 2013

Teas Extension Received

Mar 25, 2013

Applicant/Correspondence Changes (Non-Responsive) Entered

Mar 25, 2013

Teas Change Of Owner Address Received

Mar 25, 2013

Attorney Revoked And/Or Appointed

Mar 25, 2013

Teas Revoke/Appoint Attorney Received

Oct 10, 2012

Notice Of Approval Of Extension Request E-Mailed

Oct 8, 2012

Extension 1 Granted

Oct 8, 2012

Extension 1 Filed

Oct 8, 2012

Teas Extension Received

Apr 24, 2012

Noa E-Mailed - Sou Required From Applicant

Feb 28, 2012

Official Gazette Publication Confirmation E-Mailed

Feb 28, 2012

Published For Opposition

Feb 8, 2012

Notification Of Notice Of Publication E-Mailed

Jan 26, 2012

Law Office Publication Review Completed

Jan 25, 2012

Assigned To Lie

Jan 7, 2012

Approved For Pub - Principal Register

Jan 6, 2012

Assigned To Examiner

Oct 22, 2011

New Application Office Supplied Data Entered In Tram

Oct 21, 2011

New Application Entered In Tram